THC Therapeutics
Financial ratios & Valuation

Historical Multiples (2014 – 2023)

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 TTM Median
Valuation Ratios
Price/Earnings ratio
-1.78-3.62-11.76-1.33-5.49-1.48-0.48-1.03-1.10-0.25-0.02-5.49
Price/Sales ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Price/Book Value ratio
-5.45-3.71-7.494.2917.41-46.76-0.65-1.02-0.46-0.02-0.01-0.01
Price/Cash Flow ratio
-11.21-86.57-62.51-132.91-177.49-106.26-1.97-6.51-3.42-1.15-0.19-177.49
Price/Free Cash Flow ratio
-11.21-86.57-62.51-117.87-177.00-105.88-1.97-6.51-3.42-1.15-0.19-177.00
Price/Earnings Growth ratio
0.030.070.16-0.000.07-0.000.000.030.010.00-0.00-0.00
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Operating Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Pretax Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Net Profit Margin
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Effective Tax Rate
4.00%N/A13.18%-97.24%-2.40%-1.30%-25.33%-29.26%14.95%N/AN/A-2.40%
Return on Assets
-317.60%-156.24%-52.33%-302.33%-243.67%-4540.31%-2827.17%-507.67%-624.37%-2979.49%-5593.75%-4540.31%
Return On Equity
305.56%102.46%63.68%-321.72%-316.77%3150.58%135.65%98.38%41.53%11.69%82.11%-316.77%
Return on Capital Employed
293.25%98.49%64.27%-8.84%-309.16%3561.47%74.12%39.53%58.00%15.38%31.85%-309.16%
Liquidity Ratios
Current Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A0.00N/A
Quick Ratio
0.010.010.000.250.000.360.020.100.010.000.000.36
Cash ratio
0.010.010.000.000.000.250.020.100.000.000.000.25
Days of Sales Outstanding
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Inventory outstanding
N/AN/AN/AN/AN/AN/AN/A18.500.73N/AN/AN/A
Operating Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Days of Payables Outstanding
N/AN/AN/A2.85K2.55K2.26K10.36K21.63K46.77K507.44KN/A2.26K
Cash Conversion Cycle
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Debt Ratios
Debt Ratio
0.860.931.030.030.130.345.031.583.8760.9291.490.13
Debt Equity Ratio
-0.83-0.61-1.250.030.17-0.23-0.24-0.30-0.25-0.23-0.99-0.23
Long-term Debt to Capitalization
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Total Debt to Capitalization
-5.07-1.584.940.030.14-0.31-0.31-0.44-0.34-0.31N/AN/A
Interest Coverage Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A-20.57N/A
Cash Flow to Debt Ratio
-0.58-0.07-0.09-0.97-0.56-1.85-1.36-0.51-0.52-0.10N/A-0.56
Company Equity Multiplier
-0.96-0.65-1.211.061.30-0.69-0.04-0.19-0.06-0.00-0.01-0.01
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Free Cash Flow / Operating Cash Flow Ratio
1111.121.001.001110.9911.00
Cash Flow Coverage Ratio
-0.58-0.07-0.09-0.97-0.56-1.85-1.36-0.51-0.52-0.10N/A-0.56
Short Term Coverage Ratio
-0.58-0.07-0.09-0.97-0.56-1.85-1.36-0.51-0.52-0.10-0.60-1.85
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A